China Universal Asset Management Co., Ltd. Vir Biotechnology, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 26,280 shares of VIR stock, worth $227,059. This represents 0.02% of its overall portfolio holdings.
Number of Shares
26,280
Previous 15,986
64.39%
Holding current value
$227,059
Previous $142,000
38.03%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding VIR
# of Institutions
220Shares Held
87.6MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$144 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$113 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$48.6 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$30.9 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.15B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...